Chuang‐Ye Hong

846 total citations
31 papers, 716 citations indexed

About

Chuang‐Ye Hong is a scholar working on Hepatology, Pharmacology and Epidemiology. According to data from OpenAlex, Chuang‐Ye Hong has authored 31 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 8 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Chuang‐Ye Hong's work include Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Chuang‐Ye Hong is often cited by papers focused on Liver Disease and Transplantation (13 papers), Liver Disease Diagnosis and Treatment (6 papers) and Eicosanoids and Hypertension Pharmacology (6 papers). Chuang‐Ye Hong collaborates with scholars based in Taiwan, China and Myanmar. Chuang‐Ye Hong's co-authors include Ming‐Shi Shiao, Shing‐Jong Lin, Yi‐Tsau Huang, Yih‐Jer Wu, Sien‐Hung Yang, Chia‐Li Yu, Yau‐Huei Wei, Wing‐Yiu Lui, Han‐Chieh Lin and Jen‐Hwey Chiu and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, Journal of Hepatology and Biochemical Pharmacology.

In The Last Decade

Chuang‐Ye Hong

30 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chuang‐Ye Hong Taiwan 17 228 169 133 131 92 31 716
Chi Man Koon Hong Kong 19 324 1.4× 303 1.8× 128 1.0× 230 1.8× 94 1.0× 39 1000
Huquan Yin South Korea 18 440 1.9× 85 0.5× 72 0.5× 124 0.9× 40 0.4× 27 1.1k
Ihab T. Abdel‐Raheem Egypt 12 138 0.6× 70 0.4× 141 1.1× 180 1.4× 43 0.5× 23 755
Yi-Tsau Huang Taiwan 17 336 1.5× 237 1.4× 79 0.6× 260 2.0× 23 0.3× 22 964
Soon Shik Shin South Korea 18 284 1.2× 84 0.5× 106 0.8× 112 0.9× 11 0.1× 44 692
Jinjun Wu China 19 513 2.3× 190 1.1× 190 1.4× 353 2.7× 22 0.2× 39 1.1k
İrfan Değirmenci Türkiye 17 218 1.0× 75 0.4× 66 0.5× 83 0.6× 12 0.1× 58 776
Te-Mao Li Taiwan 18 394 1.7× 66 0.4× 109 0.8× 71 0.5× 33 0.4× 20 877

Countries citing papers authored by Chuang‐Ye Hong

Since Specialization
Citations

This map shows the geographic impact of Chuang‐Ye Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuang‐Ye Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuang‐Ye Hong more than expected).

Fields of papers citing papers by Chuang‐Ye Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chuang‐Ye Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuang‐Ye Hong. The network helps show where Chuang‐Ye Hong may publish in the future.

Co-authorship network of co-authors of Chuang‐Ye Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Chuang‐Ye Hong. A scholar is included among the top collaborators of Chuang‐Ye Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuang‐Ye Hong. Chuang‐Ye Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Chao‐Hsiun, et al.. (2016). Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort. Journal of the American Heart Association. 5(1). 27 indexed citations
2.
Hong, Chuang‐Ye & Fumei Wang. (2014). Chinese translation of English textbooks on internal medicine from the 1850s to the 1940s. Journal of the Chinese Medical Association. 77(6). 277–282. 1 indexed citations
3.
Tang, Chao‐Hsiun, et al.. (2013). Renin–Angiotensin System Blockade in Heart Failure Patients on Long-Term Haemodialysis in Taiwan. European Journal of Heart Failure. 15(10). 1194–1202. 21 indexed citations
4.
Chen, Yen‐Ling, Shih‐Hurng Loh, Po‐Yuan Chen, et al.. (2009). MAGNOLOL DEPRESSES UROTENSIN‐II‐INDUCED CELL PROLIFERATION IN RAT CARDIAC FIBROBLASTS. Clinical and Experimental Pharmacology and Physiology. 36(7). 711–716. 16 indexed citations
5.
Yang, Sien‐Hung, Chuang‐Ye Hong, & Chia‐Li Yu. (2002). The stimulatory effects of nasal discharge from patients with perennial allergic rhinitis on normal human neutrophils are normalized after treatment with a new mixed formula of Chinese herbs. International Immunopharmacology. 2(12). 1627–1639. 17 indexed citations
8.
Huang, Yi‐Tsau, Han‐Chieh Lin, Ying‐Ying Yang, et al.. (2001). Hemodynamic Effects of Synephrine Treatment in Portal Hypertensive Rats. The Japanese Journal of Pharmacology. 85(2). 183–188. 20 indexed citations
9.
Chiu, Jen‐Hwey, et al.. (1999). Effect of Magnolol onin VitroMitochondrial Lipid Peroxidation and Isolated Cold-Preserved Warm-Reperfused Rat Livers. Journal of Surgical Research. 82(1). 11–16. 24 indexed citations
10.
Hong, Chuang‐Ye, et al.. (1999). Measurement and pharmacokinetic study of tetramethylpyrazine in rat blood and its regional brain tissue by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 724(2). 303–309. 37 indexed citations
11.
Huang, Yi‐Tsau, et al.. (1999). Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats. Canadian Journal of Physiology and Pharmacology. 77(8). 618–624. 17 indexed citations
12.
Huang, Yi‐Tsau, et al.. (1999). Haemodynamic effects of chronic tetramethylpyrazine administration on portal hypertensive rats. European Journal of Gastroenterology & Hepatology. 11(9). 1027–1032. 3 indexed citations
13.
Chen, Keji, et al.. (1999). Acute Hemodynamic Effects of Tetramethylpyrazine and Tetrandrine on Cirrhotic Rats. Planta Medica. 65(2). 130–134. 13 indexed citations
14.
Huang, Yi-Tsau, et al.. (1998). Portal Hypotensive Effects of DL-028 and Prazosin on Portal Hypertensive Rats. Pharmacology. 57(3). 132–138. 2 indexed citations
15.
Lin, Han‐Chieh, May C.M. Yang, Yi‐Tsau Huang, et al.. (1997). The Hemodynamic Effects of AT-112, an Analog of Ketanserin, in Portal Hypertensive Rats. Pharmacology. 54(1). 16–23. 7 indexed citations
16.
Chiu, Jen‐Hwey, et al.. (1997). In vitro and in vivo protective effect of honokiol on rat liver from peroxidative injury. Life Sciences. 61(19). 1961–1971. 48 indexed citations
17.
Huang, Yi‐Tsau, et al.. (1996). Chronic Administration of Octreotide Increases Vascular Responsiveness in Rats with Portal Hypertension. Clinical Science. 91(5). 601–606. 14 indexed citations
18.
Chen, Chieh-Fu, et al.. (1995). Fructus aurantii reduced portal pressure in portal hypertensive rats. Life Sciences. 57(22). 2011–2020. 48 indexed citations
19.
Kuo, Yu‐Min, et al.. (1992). Purification of a sperm motility stimulator from porcine follicular fluid. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 101(4). 591–594. 19 indexed citations
20.
Wei, Yau‐Huei, et al.. (1985). Inhibition of the mitochondrial Mg2+-ATPase by propranolol. Biochemical Pharmacology. 34(7). 911–917. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026